نتایج جستجو برای: neu references

تعداد نتایج: 65582  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2000
E R Andrechek W R Hardy P M Siegel M A Rudnicki R D Cardiff W J Muller

The neu (c-erbB-2, Her-2) protooncogene is amplified and overexpressed in 20-30% of human breast cancers. Although transgenic mouse models have illustrated the role of Neu in the induction of mammary tumors, Neu expression in these models is driven by a strong viral promoter of questionable relevance to the human disease. To ascertain whether expression of activated Neu under the control of the...

Journal: :Anticancer research 2004
Diana Lüftner Isabelle Genvresse Rita Geppert Olaf Kaufmann Manfred Dietel Kurt Possinger

OBJECTIVES The HER-2/neu oncogene is overexpressed in many types of cancer and especially in 25% to 30% of breast cancers. Single reports mention HER-2/neu positivity in hematological malignancies like Hodgkins's disease and even diffuse large-cell lymphoma. OBJECTIVE To test for HER-2/neu overexpression in patients with non-Hodgkin's lymphoma and the possible role of the recombinant monoclon...

Journal: :Chemistry & Biology 1996

Journal: :Journal of Industrial & Engineering Chemistry 1920

Journal: :Septentrio Conference Series 2015

Journal: :Journal of Computer Science and Cybernetics 2016

Journal: :Publications of the Seto Marine Biological Laboratory. Special Publication Series. 2011

Journal: :The Journal of Experimental Medicine 2005
Anne M. Ercolini Brian H. Ladle Elizabeth A. Manning Lukas W. Pfannenstiel Todd D. Armstrong Jean-Pascal H. Machiels Joan G. Bieler Leisha A. Emens R. Todd Reilly Elizabeth M. Jaffee

A major barrier to successful antitumor vaccination is tolerance of high-avidity T cells specific to tumor antigens. In keeping with this notion, HER-2/neu (neu)-targeted vaccines, which raise strong CD8(+) T cell responses to a dominant peptide (RNEU(420-429)) in WT FVB/N mice and protect them from a neu-expressing tumor challenge, fail to do so in MMTV-neu (neu-N) transgenic mice. However, tr...

Journal: :Anticancer research 2004
László Mándoky Lajos Géczi István Bodrogi József Tóth Orsolya Csuka Miklós Kásler Mihály Bak

BACKGROUND Amplification and/or overexpression of HER-2/neu are associated with poor clinical outcome in several epithelial tumors. However, the exact prognostic role of HER-2/neu expression in testicular germ-cell tumors is equivocal. PATIENTS AND METHODS Since teratomas are relatively chemoresistant tumors, we evaluated the HER-2/neu alterations of 59 primary testicular teratomas and mixed ...

2016
Sebastian P. Haen Benjamin J. Schmiedel Kathrin Rothfelder Bastian J. Schmied Truong-Minh Dang Nora Mirza Robert Möhle Lothar Kanz Wichard Vogel Helmut R. Salih

The epidermal growth factor receptor HER2/neu is expressed on various cancers and represents a negative prognostic marker, but is also a target for the therapeutic monoclonal antibody Trastuzumab. In about 30% of cases, HER2/neu is expressed on acute lymphoblastic leukemia (ALL) cells and was proposed to be associated with a deleterious prognosis. Here we evaluated clinical data from 65 ALL pat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید